Coordinated cellular programmes distinguish responses to neoadjuvant PD-L1 blockade and potentiate combinatorial immunotherapy in ESCC

Authors:

Abstract
Background: Programmed death ligand 1 (PD-L1) blockade offers new therapeutic options for oesophageal squamous cell carcinoma (ESCC); however, the underlying mechanisms and associated biomarkers that determine treatment response remain unclear. Objective: We delineate the mechanisms underlying the response and resistance, and elucidate the immune features that enhance neoadjuvant PD-L1 blockade efficacy in ESCC. Design: Here, we characterise the cellular dynamics following neoadjuvant PD-L1 blockade via analysing the single-cell transcriptomes of 210 978 cells and spatial transcriptomes of 20 tissue sections. Results: We identify coordinated cellular programmes centred on CXCL13 + CD8 + exhausted T cells, TNFRSF9 + CD4 + regulatory T cells, atypical memory B cells and APOE + macrophages, which coordinate the responses to neoadjuvant PD-L1 blockade at baseline. In post-treatment non-responder ESCCs, the cellular programmes exhibit an immunosuppressive phenotype, leading to the failure of therapeutic benefits. Furthermore, we reveal that lymphocyte activation gene 3 serves as a potential target and can potentiate the response via perturbation of the coordinated cellular programmes. Conclusions: Overall, our findings unravel the coordinated cellular programmes associated with treatment response, providing insights for prioritising individualised immunotherapy strategies in ESCC. Trial registration number: ChiCTR2400083452.
Funding Information
  • National Natural Science Foundation of China (32322020)
  • National Natural Science Foundation of China (32570796)
  • National Natural Science Foundation of China (32571671)
  • National Natural Science Foundation of China (92574205)
  • National Natural Science Foundation of China (T2325009)
  • Natural Science Foundation of Heilongjiang Province (JQ2025C005)
  • National Key Research and Development Program of China (2024YFF1206602)

This publication has 46 references indexed in Scilit: